Review



p-s10 histone h3 antibody  (Jackson Immuno)


Bioz Verified Symbol Jackson Immuno is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Jackson Immuno p-s10 histone h3 antibody
    P S10 Histone H3 Antibody, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p-s10 histone h3 antibody/product/Jackson Immuno
    Average 90 stars, based on 1 article reviews
    p-s10 histone h3 antibody - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    90
    Cell Signaling Technology Inc primary antibody phosphorylation of histone h3 at serine 10 (p-h3(s10)) monoclonal antibody 53348
    Primary Antibody Phosphorylation Of Histone H3 At Serine 10 (P H3(S10)) Monoclonal Antibody 53348, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody phosphorylation of histone h3 at serine 10 (p-h3(s10)) monoclonal antibody 53348/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibody phosphorylation of histone h3 at serine 10 (p-h3(s10)) monoclonal antibody 53348 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Jackson Immuno p-s10 histone h3 antibody
    P S10 Histone H3 Antibody, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p-s10 histone h3 antibody/product/Jackson Immuno
    Average 90 stars, based on 1 article reviews
    p-s10 histone h3 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc anti p s10 h3 primary antibodies
    (A) Representative immunofluorescence images showing G2 and M-phase cells stained with p-S46 TCTP, <t>p-S10</t> <t>H3</t> and DAPI. (B) Representative quantitative image-based cytometry plot showing G2 and M-phase cell cycle gates as determined by staining intensity of p-S10 H3 and DAPI. (C) Cellular quantitation of p-S46 TCTP intensity in G2-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01, **** p ≤ 0.0001). (D) Cellular quantitation of p-S46 TCTP intensity in M-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001). (E) Representative immunofluorescence images showing an S-phase cell stained with RAD51, EdU, and DAPI. Individual RAD51 foci are indicated with red outline. (F) Representative quantitative image-based cytometry plot showing S-phase cell cycle gate as determined by staining intensity of EdU and DAPI. (G) Cellular quantitation of RAD51 foci number in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01). (H) Quantitation of RAD51 foci intensity in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001).
    Anti P S10 H3 Primary Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti p s10 h3 primary antibodies/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    anti p s10 h3 primary antibodies - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc rabbit p histone h3 s10
    (A) Representative immunofluorescence images showing G2 and M-phase cells stained with p-S46 TCTP, <t>p-S10</t> <t>H3</t> and DAPI. (B) Representative quantitative image-based cytometry plot showing G2 and M-phase cell cycle gates as determined by staining intensity of p-S10 H3 and DAPI. (C) Cellular quantitation of p-S46 TCTP intensity in G2-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01, **** p ≤ 0.0001). (D) Cellular quantitation of p-S46 TCTP intensity in M-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001). (E) Representative immunofluorescence images showing an S-phase cell stained with RAD51, EdU, and DAPI. Individual RAD51 foci are indicated with red outline. (F) Representative quantitative image-based cytometry plot showing S-phase cell cycle gate as determined by staining intensity of EdU and DAPI. (G) Cellular quantitation of RAD51 foci number in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01). (H) Quantitation of RAD51 foci intensity in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001).
    Rabbit P Histone H3 S10, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit p histone h3 s10/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    rabbit p histone h3 s10 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc p h3 s10
    (A) Representative immunofluorescence images showing G2 and M-phase cells stained with p-S46 TCTP, <t>p-S10</t> <t>H3</t> and DAPI. (B) Representative quantitative image-based cytometry plot showing G2 and M-phase cell cycle gates as determined by staining intensity of p-S10 H3 and DAPI. (C) Cellular quantitation of p-S46 TCTP intensity in G2-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01, **** p ≤ 0.0001). (D) Cellular quantitation of p-S46 TCTP intensity in M-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001). (E) Representative immunofluorescence images showing an S-phase cell stained with RAD51, EdU, and DAPI. Individual RAD51 foci are indicated with red outline. (F) Representative quantitative image-based cytometry plot showing S-phase cell cycle gate as determined by staining intensity of EdU and DAPI. (G) Cellular quantitation of RAD51 foci number in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01). (H) Quantitation of RAD51 foci intensity in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001).
    P H3 S10, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p h3 s10/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    p h3 s10 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    90
    Active Motif p-histon h3 (s10) antibody
    (A) Representative images of <t>phospho-H3</t> <t>S10-stained</t> nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.
    P Histon H3 (S10) Antibody, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p-histon h3 (s10) antibody/product/Active Motif
    Average 90 stars, based on 1 article reviews
    p-histon h3 (s10) antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc p s10 histoneh3
    (A) Representative images of <t>phospho-H3</t> <t>S10-stained</t> nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.
    P S10 Histoneh3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p s10 histoneh3/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    p s10 histoneh3 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc p histone h3 s10
    (A) Representative images of <t>phospho-H3</t> <t>S10-stained</t> nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.
    P Histone H3 S10, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p histone h3 s10/product/Cell Signaling Technology Inc
    Average 98 stars, based on 1 article reviews
    p histone h3 s10 - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    90
    Millipore p-histone h3 s10 06-570 antibody
    (A) Representative images of <t>phospho-H3</t> <t>S10-stained</t> nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.
    P Histone H3 S10 06 570 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p-histone h3 s10 06-570 antibody/product/Millipore
    Average 90 stars, based on 1 article reviews
    p-histone h3 s10 06-570 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative immunofluorescence images showing G2 and M-phase cells stained with p-S46 TCTP, p-S10 H3 and DAPI. (B) Representative quantitative image-based cytometry plot showing G2 and M-phase cell cycle gates as determined by staining intensity of p-S10 H3 and DAPI. (C) Cellular quantitation of p-S46 TCTP intensity in G2-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01, **** p ≤ 0.0001). (D) Cellular quantitation of p-S46 TCTP intensity in M-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001). (E) Representative immunofluorescence images showing an S-phase cell stained with RAD51, EdU, and DAPI. Individual RAD51 foci are indicated with red outline. (F) Representative quantitative image-based cytometry plot showing S-phase cell cycle gate as determined by staining intensity of EdU and DAPI. (G) Cellular quantitation of RAD51 foci number in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01). (H) Quantitation of RAD51 foci intensity in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001).

    Journal: bioRxiv

    Article Title: Potent synthetic lethality between PLK1 and EYA-family inhibitors in tumours of the central and peripheral nervous system

    doi: 10.1101/2025.01.19.633804

    Figure Lengend Snippet: (A) Representative immunofluorescence images showing G2 and M-phase cells stained with p-S46 TCTP, p-S10 H3 and DAPI. (B) Representative quantitative image-based cytometry plot showing G2 and M-phase cell cycle gates as determined by staining intensity of p-S10 H3 and DAPI. (C) Cellular quantitation of p-S46 TCTP intensity in G2-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01, **** p ≤ 0.0001). (D) Cellular quantitation of p-S46 TCTP intensity in M-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001). (E) Representative immunofluorescence images showing an S-phase cell stained with RAD51, EdU, and DAPI. Individual RAD51 foci are indicated with red outline. (F) Representative quantitative image-based cytometry plot showing S-phase cell cycle gate as determined by staining intensity of EdU and DAPI. (G) Cellular quantitation of RAD51 foci number in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, ** p ≤ 0.01). (H) Quantitation of RAD51 foci intensity in S-phase following treatment with DMSO, Benzarone (7.5 µM), Bi2536 (10 nM), or Benzarone + Bi2536 for 5.5 hrs (one-way ANOVA with Tukey’s multiple comparison test, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001).

    Article Snippet: Cells were incubated with anti-p-S46 TCTP (Cell Signalling 5251) and anti-p-S10 H3 primary antibodies (Cell Signalling 9701) overnight at 4 ° C followed by 3 x 10 minute washes in PBS.

    Techniques: Immunofluorescence, Staining, Cytometry, Quantitation Assay, Comparison

    (A) Representative images of phospho-H3 S10-stained nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.

    Journal: Cell reports

    Article Title: FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination

    doi: 10.1016/j.celrep.2023.113523

    Figure Lengend Snippet: (A) Representative images of phospho-H3 S10-stained nuclei (blue), EdU foci (green), and FANCD2 (red) foci from APH-treated RPE-1 wild-type and PCNA K164R cell lines. EdU foci almost exclusively (>95%) colocalized with FANCD2 foci. Scale bar, 5 μm. (B) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. FANCD2 foci overlapped with EdU foci in 98% of nuclei. (C) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), RAD18 −/− (salmon), and RAD18 −/− ;PCNA K164R (pink) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ***p < 0.001. (D) FANCD2 foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (E) EdU foci quantification from two biological replicates in 293T wild-type (blue) and PCNA K164R cells (maroon) treated with 450 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by one-way ANOVA with Tukey’s multiple comparison test with ***p < 0.001. (F) Western blot analyses of chromatin associated PCNA, with or without 40 J/m 2 UV treatment, with histone H2AX as the loading control from RPE-1 wildtype, PCNA K164R , and reverted PCNA K164 cells. (G) FANCD2 foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001. (H) EdU foci quantification from two biological replicates in RPE-1 wild-type (blue), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p < 0.001.

    Article Snippet: p -Histon H3 (S10) , Active Motif , 61623 RRID:AB_2793707.

    Techniques: Staining, Comparison, Western Blot, Control

    (A) Representative images of phospho-H3 S10-stained nuclei (blue), EdU foci (green), and PLA foci (red) from APH-treated RPE-1 cells. Scale bar, 5 μm. (B) PLA foci quantification from at least three biological replicates in RPE-1 wild-type (blue), FANCD2 −/− (green), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p > 0.001. (C) Quantification of overlapping PLA and EdU foci from at least three biological replicates in RPE-1 wild-type (blue), FANCD2 −/− (green), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. (D) In wild-type (PCNA K164 ) cells (left), PCNA is ubiquitinated at K164 in response to replication stress by RAD18. During S phase, this facilitates the switch from processive DNA polymerase to TLS polymerases (for example, Pol η) to complete DNA synthesis. At alternative loci, ubiquitinated PCNA promotes the ubiquitination and chromatin association of FANCD2. During G2/M phase, PCNA recruits subunits of TLS Pol ζ to FANCD2-marked foci to initiate MiDAS and then facilitates processive replication through association with components of Pol δ. In mutant (PCNA K164R ) cells (right), PCNA ubiquitination is impaired. Subsequently, TLS polymerase and FANCD2 recruitment to stressed replication forks is reduced in S and G2/M phases, causing the persistence of under-replicated genomic loci.

    Journal: Cell reports

    Article Title: FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination

    doi: 10.1016/j.celrep.2023.113523

    Figure Lengend Snippet: (A) Representative images of phospho-H3 S10-stained nuclei (blue), EdU foci (green), and PLA foci (red) from APH-treated RPE-1 cells. Scale bar, 5 μm. (B) PLA foci quantification from at least three biological replicates in RPE-1 wild-type (blue), FANCD2 −/− (green), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. Significance was calculated by Kruskal-Wallis with Dunn’s multiple comparison test with ****p > 0.001. (C) Quantification of overlapping PLA and EdU foci from at least three biological replicates in RPE-1 wild-type (blue), FANCD2 −/− (green), PCNA K164R (maroon), and reverted PCNA K164 (purple) cells treated with 300 nM APH. Number (n) of nuclei quantified is listed. (D) In wild-type (PCNA K164 ) cells (left), PCNA is ubiquitinated at K164 in response to replication stress by RAD18. During S phase, this facilitates the switch from processive DNA polymerase to TLS polymerases (for example, Pol η) to complete DNA synthesis. At alternative loci, ubiquitinated PCNA promotes the ubiquitination and chromatin association of FANCD2. During G2/M phase, PCNA recruits subunits of TLS Pol ζ to FANCD2-marked foci to initiate MiDAS and then facilitates processive replication through association with components of Pol δ. In mutant (PCNA K164R ) cells (right), PCNA ubiquitination is impaired. Subsequently, TLS polymerase and FANCD2 recruitment to stressed replication forks is reduced in S and G2/M phases, causing the persistence of under-replicated genomic loci.

    Article Snippet: p -Histon H3 (S10) , Active Motif , 61623 RRID:AB_2793707.

    Techniques: Staining, Comparison, DNA Synthesis, Ubiquitin Proteomics, Mutagenesis

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination

    doi: 10.1016/j.celrep.2023.113523

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: p -Histon H3 (S10) , Active Motif , 61623 RRID:AB_2793707.

    Techniques: Recombinant, Electron Microscopy, Plasmid Preparation, In Situ, Sequencing, Software, Imaging, Flow Cytometry, Transfection, Microscopy